Scott Morrison brings over 35 years of financial experience helping life sciences companies excel from start-up, through initial product launch, to global expansion.
Mr. Morrison has served as Ernst & Young’s U.S. Life Sciences Leader since 2002 (retired December 2015). He has worked on hundreds of public and private financings, including more than 40 IPOs and 100 follow-on offerings and is considered a recognized expert in the M&A arena. Mr. Morrison has a long history of contributions to nonprofit and industry organizations and has previously served on the boards of the Life Sciences Foundation, Bay Area Biosciences Association, the Emerging Companies Section of the Biotechnology Innovation Organization (BIO) and the Biotechnology Institute. Mr. Morrison currently serves on the boards of Audentes Therapeutics, Corvus Pharmaceuticals and Symic Bio.
Mr. Morrison graduated from the University of California, Berkeley and is a Certified Public Accountant (inactive).